← Back to Events
Tier 1 Global Networking: High ONCOLOGY CONCLUDED
ASCO 2026 — McCormick Place, Chicago, United States
The 2026 ASCO Annual Meeting is The Place to Be. Learn more about the sessions, speakers, and science that will be presented at this year's meeting below. Answer who/what/when/where for ASCO 2026 Program pdf with verified dates, location, and what B2B readers should watch. ASCO 2
45,000+ Attendees
9 Presentations
7 Companies
7 Drugs
Presentation data updated Jun 5, 2026, 9:21 AM UTC
Nova Event Impact Score
59 /100
- Media coverage 10/20
- Speaker quality 20/20
- Pipeline relevance 2/20
- Historical influence 13/20
- Company participation 14/20
Key Takeaways
Key Themes
oncologycongressPipeline announcementsPartnership deals
Key Companies
Gilead SciencesAmgenMerck & Co.Johnson & JohnsonPfizer
Key Drugs
pembrolizumabsotorasibsacituzumab tirumotecanamivantamabpumitamig
Key Markets
US Americas
Key Opportunities
Partnership dealsLicensing discussionsVendor selection
Oncology BD teams Clinical development leaders Investors & analysts
Johnson & Johnson at ASCO 2026
Johnson & Johnson$JNJ Company profile linked when published in our directory.
ORAL Jun 5
Updated results from the open-label Phase I/Ib CHRYSALIS-2 study (NCT04077463) of amivantamab and lazertinib in non-small cell lung cancer